Platelet Aggregation Inhibitors/adverse effects

Harris, J., Pouwels, K. B., Johnson, T., Sterne, J., Pithara, C., Mahadevan, K., et al. (2023). Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies. Health Technol Assess, 27, 1-257.
Pufulete, M., Harris, J., Pouwels, K., Reeves, B. C., Lasserson, D., Loke, Y. K., et al. (2022). Real-world bleeding in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and prescribed different combinations of dual antiplatelet therapy (DAPT) in England. Open Heart, 9.